Post on 17-Mar-2020
transcript
Planner Disclosure Summary
Name of Individual Individual's
Role(s) in
Activity
Name of Commercial Interest(s) Nature of Relationship(s)
Aerts, Joachim Education
Committee
1) BMS, Roche, Eli-Lilly, Boehringer Ingelheim, Takeda, MSD, Astra-
Zeneca, Amphera
2) Amphera
3) Allogenic Tumor-Cell Lysate, Combination Immunotherapy in
Oncology, Biomarker for Immunooncology
1) Advisory Board
2) Ownership or Stock Interest
3) Royalty, Intellectual
Property/Patent Holder
Aggarwal, Charu Planner 1) BMS, ROCHE, AZ, MERCK, Celgene
2) Allogenic tumor cell lysate/JAK inhibition in immuno-
oncology/biomarker for immuno-oncology (all institution)
1) Advisory Board
2) Royalties/Intellectual
Property/Patent Holder
Ahmed, Aneez Planner Nothing to disclose Nothing to disclose
Ahn, Myung-Ju Planner 1) Lilly, AstraZeneca, TAKEDA, Roche, BMS, Amgen
2) Lilly, AstraZeneca, TAKEDA, Roche, Alpha pharmaceutical
company
1) Advisory Board
2) Consultant
Aisner, Dara Planner 1) Presenter at CME Symposium for PeerView, Clinical Care
Options, Medscape (CME companies)
1) Other
Anantham,
Devanand
Planner Nothing to disclose Nothing to disclose
Andarini, Sita Planner 1) Astra Zeneca, Boehringer Ingelheim, MSD, Kalbe Innolab, Pfizer,
Roche, Takeda
2) Astra Zeneca, Boehringer Ingelheim, MSD, Roche
3) Astra Zeneca, Boehringer Ingelheim
1) Speakers Bureau
2) Advisory Board
3) Contracted/Supported Research
Grant
Ang, Mei-Kim Planner Nothing to disclose Nothing to disclose
Antonoff, Mara Planner Nothing to disclose Nothing to disclose
Araujo, Antonio Education
Committee
Nothing to disclose Nothing to disclose
Awad, Mark Planner 1) Achilles, Abbvie, Neon, Maverick, Blueprint
2) AstraZeneca, Lilly, Bristol-Myers Squibb, Genentech
1) Consultant
2) Contracted/Supported Research
Grant
Baas, Paul Planner 1) MSD, BMS, Pfizer, AZ and Takeda
2) MSD, BMS
3) MSD, BMS, Roche
1) Advisory Board
2) Consultant
3) Contracted/Supported Research
Grant
Babu, K. Govind CME Liaisons Nothing to disclose Nothing to disclose
Badawy, Ahmed Education
Committee
Nothing to disclose Nothing to disclose
Baldwin, David Planner Nothing to disclose Nothing to disclose
Page 1 of 16
Planner Disclosure Summary
Name of Individual Individual's
Role(s) in
Activity
Name of Commercial Interest(s) Nature of Relationship(s)
Barlesi, Fabrice Planner 1) Astra-Zeneca, Bayer, Bristol-Myers Squibb,
Boehringer–Ingelheim, Eli Lilly Oncology, F. Hoffmann–La Roche
Ltd, Novartis, Merck, MSD, Pierre Fabre, Pfizer and Takeda
2) Astra-Zeneca, Bayer, Bristol-Myers Squibb,
Boehringer–Ingelheim, Eli Lilly Oncology, F. Hoffmann–La Roche
Ltd, Novartis, Merck, MSD, Pierre Fabre, Pfizer and Takeda
3) Abbvie, ACEA, Amgen, Astra-Zeneca, Bayer, Bristol-Myers
Squibb, Boehringer–Ingelheim, Eisai, Eli Lilly Oncology, F.
Hoffmann–La Roche Ltd, Genentech, Ipsen, Ignyta, Innate Pharma,
Loxo, Novartis, Medimmune, Merck, MSD, Pierre Fabre, Pfizer,
Sanofi-Aventis and Takeda
1) Advisory Board
2) Consultant
3) Contracted/Supported Research
Grant
Beattie, Vanessa Planner Nothing to disclose Nothing to disclose
Bironzo, Paolo Planner 1) BMS, MSD, BI, Astra Zeneca, Roche 1) Honorarium received from
promotional activities
Black, Kirsten Staff Liaison Nothing to disclose Nothing to disclose
Blackhall, Fiona Planner 1) Me Astra Zeneca
2) Me Abbvie Roche
3) Me AZ Cellgene Roche Amgen
4) me AZ Roche Amgen
1) Speakers Bureau
2) Advisory Board
3) Consultant
4) Contracted/Supported Research
Grant
Blackmon, Shanda Planner 1) Olympus
2) Boston Scientific, medtronic, Olympus
3) Medtronic, TruFreeze
4) Esophageal Anastomotic Device- with Boston Scientific
1) Speakers Bureau
2) Advisory Board
3) Contracted/Supported Research
Grant
4) Honorarium received from
promotional activities
Borghaei, Hossein Planner 1) Genentech, Celgene, Pfizer, Merck, Astra Zeneca, Novartis,
Genmab, Regeneron, BioNTech, Cantargia AB, Amgen, Axiom
2) Abbvie,BMS, Lilly,EMD-Serono,Boehringer Ingelheim, DSMB:
Takeda
3) Lilly
4) BMS/Lilly, Merck/Celgene, Millennium
1) Advisory Board
2) Consultant
3) Honorarium received from
promotional activities
4) Contracted/Supported Research
Grant
Bubendorf, Lukas Planner 1) Boehringer Ingelheim, Astra Zeneca , Eli Lilly, Bayer
2) Roche, Novartis
3) Bayer
4) Roche
1) Advisory Board
2) Ownership/Stock Interest
3) Honorarium received from
promotional activities
4) Contracted/Supported Research
Grant
Page 2 of 16
Planner Disclosure Summary
Name of Individual Individual's
Role(s) in
Activity
Name of Commercial Interest(s) Nature of Relationship(s)
Cardona Zorrilla,
Andres Felipe
Planner 1) Roche, BI, Pfizer, Novartis, Astra, Amgen, BMS, MSD
2) Roche, BI, Pfizer, Novartis, Celldex, Astra Zeneca, Astellas,
Amgen, MSD, Merck Serono
3) Roche, BI, Pfizer, Novartis, Celldex, Astra Zeneca, Astellas,
Amgen, MSD, Merck Serono
4) Foundation for Clinical and Applied Cancer Research - FICMAC
5) Roche, BI, Novartis, BMS, Abbie, Celldex, Idilla, Termo Fisher,
Illumina
6) CLINICA DEL COUNTRY
7) Conquer Cancer Foundation
1) Speakers Bureau
2) Advisory Board
3) Consultant
4) Ownership/Stock Interest
5) Honorarium received from
promotional activities
6) Financial support or relationship
with tobacco and/or e-cigarette
company
7) Contracted/Supported Research
Grant
Cedzynska,
Magdalena
Planner Nothing to disclose Nothing to disclose
Chaft, Jamie Planner 1) BMS, AZ, Genentech, Merck
2) BMS, AZ, Genentech, Merck
1) Advisory Board
2) Contracted/Supported Research
Grant
Chan, Alexandre Planner Nothing to disclose Nothing to disclose
Chang, Yeun-
Chung
Planner Nothing to disclose Nothing to disclose
Cheng, Ying Planner Nothing to disclose Nothing to disclose
Chi, Alexander Planner 1) TK Healthcare 1) Financial support or relationship
with tobacco and/or e-cigarette
company
Chiappori, Alberto Planner 1) Takeda, Merck, Novartis, Genentech, Celgene
2) Astra Zeneca, BMS, Novartis, Amgen, Pfizer
3) Takeda, Merck, Novartis, Genentech, Celgene
4) Astra Zeneca, BMS, Novartis
1) Speakers Bureau
2) Advisory Board
3) Honorarium received from
promotional activities
4) Contracted/Supported Research
Grant
Chin, Venessa Planner 1) Myself, advisory board member, AstraZeneca
2) Myself, paid invited speaker at educational event, Bohringer
Ingelheim
1) Advisory Board
2) Other
Cho, Byoung Chul Planner 1) Norvatis(Recipient:You)
2) Novartis, Bayer, AstraZeneca, MOGAM Institute, Dong-A ST,
Champions Oncology, Janssen, Yuhan, Ono, Dizal Pharma,
MSD(Recipient:You)
3) Novartis, AstraZeneca, Boehringer-Ingelheim, Roche, BMS, Ono,
Yuhan, Pfizer, Eli Lilly, Janssen, Takeda, MSD(Recipient:You)
4) TheraCanVac Inc, Gencurix Inc, Bridgebio
therapeutics(Recipient:You)
5) Novartis, Bayer, AstraZeneca, MOGAM Institute, Dong-A ST,
Champions Oncology, Janssen, Yuhan, Ono, Dizal Pharma,
MSD(Recipient:You)
6) Novartis, Bayer, AstraZeneca, MOGAM Institute, Dong-A ST,
Champions Oncology, Janssen, Yuhan, Ono, Dizal Pharma,
MSD(Recipient:You)
7) Champions Oncology(Recipient:You)
1) Speakers Bureau
2) Advisory Board
3) Consultant
4) Ownership/Stock Interest
5) Honorarium received from
promotional activities
6) Contracted/Supported Research
Grant
7) Royalties/Intellectual
Property/Patent Holder
Page 3 of 16
Planner Disclosure Summary
Name of Individual Individual's
Role(s) in
Activity
Name of Commercial Interest(s) Nature of Relationship(s)
Chou, Teh-Ying Planner 1) Roche
2) Roche
3) Roche
1) Speakers Bureau
2) Advisory Board
3) Consultant
Choy, Hak Planner 1) Merck, AZ 1) Advisory Board
Chua, Kevin Planner 1) Myself: Astrazeneca & Varian Medical Systems
2) Myself: Astrazeneca
3) Myself: National Cancer Centre Singapore
1) Speakers Bureau
2) Advisory Board
3) Employment
Chung, Jin-Haeng Planner Nothing to disclose Nothing to disclose
Cooper, Wendy Planner Nothing to disclose Nothing to disclose
Cui, Jiuwei Planner 1) The First Hospital of Jilin University 1) Financial support or relationship
with tobacco and/or e-cigarette
company
Culligan, Melissa Planner 1) University of Maryland Medical Center 1) Financial support or relationship
with tobacco and/or e-cigarette
company
Currow, David Planner 1) I am an unpaid advisory board member for Helsinn
Pharmaceuticals
2) I am a paid consultant and receives payment for intellectual
property with Mayne Pharma and a consultant with Specialised
Therapeutics Australia Pty. Ltd
1) Advisory Board
2) Consultant
Davies, Marianne Education
Committee
Nothing to disclose Nothing to disclose
De Koning, Harry Planner Nothing to disclose Nothing to disclose
De Lima Lopes,
Gilberto
Planner Nothing to disclose Nothing to disclose
Degi, Csaba Education
Committee
Nothing to disclose Nothing to disclose
Diehn, Maximilian Planner 1) AstraZeneca
2) Roche, BioNTech
3) CiberMed
4) Varian Medical Systems
5) Patents on cancer biomarkers
1) Advisory Board
2) Consultant
3) Ownership/Stock Interest
4) Contracted/Supported Research
Grant
5) Royalties/Intellectual
Property/Patent Holder
Donington, Jessica Planner 1) AstraZeneca
2) AstraZeneca
1) Speakers Bureau
2) Advisory Board
Dresler, Carolyn Planner Nothing to disclose Nothing to disclose
Page 4 of 16
Planner Disclosure Summary
Name of Individual Individual's
Role(s) in
Activity
Name of Commercial Interest(s) Nature of Relationship(s)
Drilon, Alexander Planner 1) Me: Ignyta/Genentech/Roche, Loxo/Bayer/Lilly,
Takeda/Ariad/Millenium, TP Therapeutics, AstraZeneca, Pfizer,
Blueprint, Helsinn, Beigene, BergenBio, Hengrui, Exelixis, Tyra,
Verastem, MORE, Abbvie
2) Me (CME Honoraria): Medscape, OncLive, PeerVoice, Physicians
Education Resources, Targeted Oncology, Research to Practice,
Oncology
3) Me (Associated Research Paid to Institution): Pfizer, Exelixis,
GlaxoSmithKlein, Teva, Taiho, PharmaMar; Me (Research):
Foundation Medicine
4) Me: Wolters Kluwer (Pocket Oncology)
5) Me (Food/Beverage): Merck, Puma
1) Advisory Board
2) Honorarium received from
promotional activities
3) Contracted/Supported Research
Grant
4) Royalties/Intellectual
Property/Patent Holder
5) Other
Duma, Narjust Planner Nothing to disclose Nothing to disclose
Duruisseaux,
Michael
Planner 1) Astra Zeneca, MSD, Boerhinger Ingelheim, BMS, Abbvie,
Novartis, Takeda
1) Advisory Board
Ekman, Simon Planner Nothing to disclose Nothing to disclose
Fang, Wentao Planner Nothing to disclose Nothing to disclose
Faseru, Babalola Planner Nothing to disclose Nothing to disclose
Feller-Kopman,
David
Planner 1) AstraZeneca
2) Veran Medical, Veracyte Inc
3) Nuvaira
4) Trizell
1) Speakers Bureau
2) Consultant
3) Ownership/Stock Interest
4) Contracted/Supported Research
Grant
Fong, Kwun Planner 1) CAD software provided for research trial by MeVIS 1) Other
Fraser, Anne Planner Nothing to disclose Nothing to disclose
Gaafar, Rabab Planner 1 ) AstraZeneca, Pfizer, Lilly Oncology
2) Protocol PI with NCI Cairo with Roche, Boehringer Ingelheim
and MSD
1) Speakers Bureau
2) Other
Gadgeel, Shirish Planner 1) Genentech/Roche, Astra-Zeneca, Pharmar, Takeda, Novocure,
Boehringer-Ingelheim, Xcovery
2) Travel Grant- Roche/Genentech
1) Advisory Board
2) Other
Gainor, Justin Planner 1) Bristol-Myers Squibb, Merck, Genentech/Roche, Takeda,
Blueprint, Loxo, Regeneron, Oncorus, Pfizer, Amgen
2) Ironwood Pharmaceuticals (Spouse)
3) Novartis, Takeda, Genentech/Roche
4) Employment - Ironwood Pharmaceuticals (spouse)
1) Advisory Board
2) Ownership/Stock Interest
3) Contracted/Supported Research
Grant
4) Other
Galateau Salle,
Francoise
Planner Nothing to disclose Nothing to disclose
Ganti, Apar Kishor CME Liaisons 1) AstraZeneca
2) AstraZeneca, Genentech
3) Takeda (Research Support), Merck, Apexigen, Novartis
(Institutional PI on Multi-Center Trial)
1) Advisory Board
2) Consultant
3) Contracted/Supported Research
Grant
Page 5 of 16
Planner Disclosure Summary
Name of Individual Individual's
Role(s) in
Activity
Name of Commercial Interest(s) Nature of Relationship(s)
Garassino, Marina
Chiara
Planner 1) Otsuka Pharma, Incyte; Eli Lilly, BMS, Roche, Celgene,
Takeda; MSD, AstraZeneca; Takeda Russia.
2) Boehringer Ingelheim, Novartis, Pfizer, Inivata, Seattle
Genetics, Daiichi-Sankyo -Incyte; Eli Lilly, BMS, Roche, Celgene,
MSD, AstraZeneca, Takeda.
3) MSD, AstraZeneca;
4) Merck KGaA - AstraZeneca AB- UNITED THERAPEUTICS
CORPORATION- F. Hoffmann-La Roche, Ltd-Incyte Corporation-
Merck Sharp & Dohme Corporation- Novartis Farma S.p.A- TAKEDA
Pharmaceuticals-SPECTRUM PHARMACEUTICALS- Exelixis Inc.-
GlaxoSmithKline S.p.A. advisory role, Steering Committee;
research funding: Spectrum Pharmaceuticals, Blueprint Medicine.
5) Patent n°/ Application n° 19185724.2-1111 date: 03/09/2019
Immunotherapy in Advanced NSCLC
1) Speakers Bureau
2) Advisory Board
3) Consultant
4) Contracted/Supported Research
Grant
5) Royalties/Intellectual
Property/Patent Holder
Garon, Edward Planner 1) Dracen, EMD Serono, Novartis (me)
2) AstraZeneca, BMS, Eli Lilly, Genentech, Novartis, Merck, Neon,
Iovance, Dynavax, Mirati
1) Advisory Board
2) Contracted/Supported Research
Grant
Gerber, David Planner 1) Gilead
2) Astra Zeneca, BerGenBio, Karyopharm, Sagimet
3) Oxford University Press, Decision Support in Medicine, Patent
pending: application number 62/461,455
1) Ownership/Stock Interest
2) Contracted/Supported Research
Grant
3) Royalties/Intellectual
Property/Patent Holder
Goldberg, Sarah Planner 1) AstraZeneca
2) Yale Cancer Center
3) AstraZeneca
1) Consultant
2) Financial support or relationship
with tobacco and/or e-cigarette
company
3) Contracted/Supported Research
Grant
Goo, Jin Mo Planner 1) Infinitt Healthcare 1) Contracted/Supported Research
Grant
Goto, Yasushi Planner 1) AstraZeneca, Eli Lilly, Chugai, Taiho Pharmaceutical,
Boehringer Ingelheim, Ono Pharmaceutical, Bristol Myers Squibb,
Pfizer, MSD, Shionogi Pharma, Novartis
2) Eli Lilly, Chugai, Taiho Pharmaceutical, Boehringer
Ingelheim,Pfizer, Novartis, AstraZeneca, Glaxo Smith Kline, MSD,
Guardant Health
3) Abbvie, Eli Lilly, Taiho Pharmaceutical, Bristol Myers Squibb,
Ono Pharmaceutical, Dai-ichi Sankyo, Pfizer, Novartis, Kyorin,
Chugai, Guardant Health
1) Speakers Bureau
2) Advisory Board
3) Contracted/Supported Research
Grant
Govindan,
Ramaswamy
Planner 1) Achilles 1) Advisory Board
Gray, Stacy Planner 1) Grail (me), Magenta (spouse) 1) Consultant
Guckenberger,
Matthias
Planner 1) AstraZeneca 1) Advisory Board
Hamzah, Ednin Planner Nothing to disclose Nothing to disclose
Hatton, Matthew Education
Committee
Nothing to disclose Nothing to disclose
Page 6 of 16
Planner Disclosure Summary
Name of Individual Individual's
Role(s) in
Activity
Name of Commercial Interest(s) Nature of Relationship(s)
Horinouchi,
Hidehito
Planner 1) AstraZeneca, ONO, BMS, Lilly, Ilumina
2) AstraZeneca, ONO, BMS, Lilly, MSD, Taiho, Kyowa-Kirin, Chugai,
Roche
3) Daiichi-Sankyo, Abbvie, ONO, BMS, MSD, Chugai, Roche
1) Advisory Board
2) Honorarium received from
promotional activities
3) Contracted/Supported Research
Grant
Horn, Leora Planner 1) Astra Zeneca, Merck, Incyte, Genentech-Roche, Xcovery, EMD
Serono, Pfizer
2) Xcovery, Amgen
3) Xcovery, Bristol Myers Squibb, Boehringer Ingelheim
4) Travel to speak at meetings Bristol Myers Squibb, Xcovery
1) Advisory Board
2) Consultant
3) Contracted/Supported Research
Grant
4) Other
Huang, Yiqing Planner Nothing to disclose Nothing to disclose
Hwangbo, Bin Planner Nothing to disclose Nothing to disclose
Ihsan, Alloubi CME Liaisons Nothing to disclose Nothing to disclose
Jacobsen
Skanderup, Anders
Planner Nothing to disclose Nothing to disclose
Jain, Amit Planner Nothing to disclose Nothing to disclose
Jain, Deepali Planner Nothing to disclose Nothing to disclose
Jassem, Jacek Planner 1) AstraZeneca, Roche, Pfizer
2) AstraZeneca, BMS, Pfizer, MSD, Takeda
3) Roche, Pfizer travel support
1) Speakers Bureau
2) Advisory Board
3) Other
Johnson, Melissa Planner 1) & 2) Genentech/Roche, Celgene, Boehringer Ingelheim, Sanofi,
Mirati, LOXO, Calithera, AstraZeneca, Merck, Araxes Pharma,
Mersana Therapeutics, BeiGene, Incyte, Pfizer, GUardant Health,
Bristol Myers-Squibb, Ribon Therapeutics
3) Research Funding - BerGenBio, Lilly, EMD Serono, Janssen,
Mirati Therapeutics, Genmab, Pfizer, AstraZeneca,
Genentech/Roche, StemCentrix, Novartis, Checkpoint
Therapeutics, Array, Regeneron, Apexigen, Abbvie, Tarveda,
Adaptiummune, Syndax, Neovia, Boehringer Ingelheim, Sanofi,
Hengrui Therapeutics, Merck, Daiichi Sankyo, Lycera, G1
Therapeutics, Dynavax, LOXO, CytomX, BeiGene, Birdie, Corvus,
Incyte, Genocea, Gritstone, Amgen, Bristol Myers-Squibb,
Kadmon, Clovis, Acerta, OncoMed, Guardant Health, Takeda,
Shattuck Labs, GlaxoSmithKline
4) Abbvie, Astellas, AstraZeneca, Boehringer Ingelheim, Clovis,
Daiichi Sankyo, EMD Serono, Bristol Myers-Squibb, Exelixis,
Genentech, Incyte, Merck, Pfizer, Sysmex Inostics, Vapotherm
1) Advisory Board
2) Consultant
3) Contracted/Supported Research
Grant
4) Other
Page 7 of 16
Planner Disclosure Summary
Name of Individual Individual's
Role(s) in
Activity
Name of Commercial Interest(s) Nature of Relationship(s)
Joubert, Philippe Planner 1) Bristol-Myers Squibb
2) AstraZeneca
3) Université Laval
4) AstraZeneca, Pfizer
1) Advisory Board
2) Consultant
3) Financial support or relationship
with tobacco and/or e-cigarette
company
4) Contracted/Supported Research
Grant
Kao, Steven Planner 1) Pfizer, Astra Zeneca, Roche, MSD, Boehringer
2) Pfizer, Astra Zeneca, Roche, MSD, BMS
3) Astra Zeneca, Pfizer
1) Advisory Board
2) Honorarium received from
promotional activities
3) Contracted/Supported Research
Grant
Kazmi, Shayma Education
Committee
Nothing to disclose Nothing to disclose
Kelly, Karen Planner 1) AbbVie, AstraZeneca, EMD Serono, Inivata, Novartis,
Regeneron, Symphogen
2) Data Monitoring Committee, AstraZeneca
3) AbbVie, EMD Serono, Genentech, Regeneron
4) UpToDate
5) Speaker, Merck, Educational Lectures (not speakers bureau)
1) Advisory Board
2) Consultant
3) Contracted/Supported Research
Grant
4) Royalties/Intellectual
Property/Patent Holder
5) Other
Kerr, Keith Planner 1) AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli
Lilly, Merck Serono, Merck Sharp & Dohme, Novartis, Pfizer,
Roche, Ventana, PER, Prime Oncology
2) AbbVie, Amgen, Archer diagnostics, AstraZeneca, Bayer,
Boehringer Ingelheim, Bristol-Myers Squibb, Merck Serono, Merck
Sharp & Dohme, Novartis, Pfizer, Roche,
1) Speakers Bureau
2) Advisory Board
Kidane, Biniam Planner Nothing to disclose Nothing to disclose
Kim, Hye Ryun Planner Nothing to disclose Nothing to disclose
Kim, Young Tae Planner Nothing to disclose Nothing to disclose
King, Jennifer Planner 1) Foundation Medicine
2) GRAIL, Merck
3) Foundation Medicine, ThermoFisher, AstraZeneca
1) Advisory Board
2) Consultant
3) Honorarium received from
promotional activities
Klebe, Sonja Planner 1) Advisory Board to advise on pathology testing in lung cancer in
Australia for MERCK. leading to publication
2) Have participated in Educational activities supported by/paid
for Astra Zeneca and Ventana Roche (no honorarium) have
received funds for research testing various antibodies for diagnosis
is lung cancer (investigator-initiated study) from Ventana/Roche, I
have received a drug to test for research from Signpath Pharma
(only drug, called lipocurc TM no funding for actual study which
was independently funded by a grant)
1) Advisory Board
2) Other
Koh, Wee Yao Planner Nothing to disclose Nothing to disclose
Kong, Feng-Ming
(Spring)
Planner 1) AstraZeneca, Roche
2) Hong Kong University and Case Western Reserve University
3) Varian Medical Inc.
1) Speakers Bureau
2) Employment
3) Contracted/Supported Research
Grant
Page 8 of 16
Planner Disclosure Summary
Name of Individual Individual's
Role(s) in
Activity
Name of Commercial Interest(s) Nature of Relationship(s)
Koong, Heng Nung Planner Nothing to disclose Nothing to disclose
Labuc, Pippa Planner Nothing to disclose Nothing to disclose
Lai, Gillianne Planner 1) $1000 SGD from Pfizer for NCCS-COE Lung and GU preceptorship 1) Honorarium received from
promotional activities
Lai, Yeur-Hur Planner Nothing to disclose Nothing to disclose
Leal, Ticiana Planner 1) AstraZeneca, Bayer, BeyondSpring, Bristol-Myers Squibb, Merck,
Takeda, Genentech
2) AstraZeneca, Novocure (Steering Committee LUNAR study)
1) Advisory Board
2) Consultant
Lee, Jay Planner 1) Genentech, AstraZeneca, Novartis
2) Merck
1) Advisory Board
2) Contracted/Supported Research
Grant
Lee, Pyng Planner Nothing to disclose Nothing to disclose
Leigh, Lillian Planner Nothing to disclose Nothing to disclose
Leighl, Natasha Planner Nothing to disclose Nothing to disclose
Li, Bob Planner 1) Guardant Health, Hengrui Therapeutics
2) Genentech, AstraZeneca, Daiichi Sankyo, Hengrui Therapeutics,
Amgen
1) Consultant
2) Contracted/Supported Research
Grant
Liam, Chong Kin Planner 1) AstraZeneca, Merck Sharp & Dohme, Boehringer Ingelheim
2) AstraZeneca, Merck Sharp & Dohme, Boehringer Ingelheim,
Pfizer
3) University of Malaya
4) AstraZeneca, Boehringer Ingelheim
1) Speakers Bureau
2) Advisory Board
3) Financial support or relationship
with tobacco and/or e-cigarette
company
4) Contracted/Supported Research
Grant
Licht, Peter Planner 1) Ethicon Johnson&Johnson: ad hoc proctor in minimally invasive
thoracic surgery in Europe
1) Other
Liew, Charlene Planner 1) Changi General Hospital 1) Financial support or relationship
with tobacco and/or e-cigarette
company
Lim, Eric Planner 1) Pfizer, Roche, Lily Oncology, Boehringer Ingelheim, Ethicon
2) AstraZeneca, Medtronic
3) Abbott Molecular, Glaxo Smith Kline
4) Medela
5) Medela, Clearbridge Biomedics, Illumina, Guardant Health
5) Clearbridge Biomedics
1) Speakers Bureau
2) Advisory Board
3) Consultant
4) Honorarium received from
promotional activities
5) Contracted/Supported Research
Grant
6) Royalties/Intellectual
Property/Patent Holder
Lin, Chia-Chi Planner 1) Novartis
2) Daiichi-Sankyo, Kelun
3) Roche
1) Advisory Board
2) Consultant
3) Honorarium received from
promotional activities
Lin, Dongmei Planner Nothing to disclose Nothing to disclose
Page 9 of 16
Planner Disclosure Summary
Name of Individual Individual's
Role(s) in
Activity
Name of Commercial Interest(s) Nature of Relationship(s)
Liu, Stephen Planner 1) Apollomics, AstraZeneca, Bristol-Myers Squibb, Celgene, G1
Therapeutics, Genentech, Guardant Health, Lilly, LOXO,
PharmaMar, Roche, Takeda/Ariad, Tempus
2) AstraZeneca, Celgene, Genentech, Janssen, Lilly, MSD, Roche,
Takeda
3) Alkermes, AstraZeneca, Bayer, Blueprint, Bristol-Myers Squibb,
Clovis, Corvus, Debiopharm, Esanex, Genentech/Roche, Ignyta,
Lilly, Lycera, Merck, Molecular Partners, OncoMed, Pfizer, Rain
Therapeutics, Turning Point Therapeutics
1) Advisory Board
2) Consultant
3) Contracted/Supported Research
Grant
Lockwood, William Planner 1) British Columbia Cancer Agency 1) Financial support or relationship
with tobacco and/or e-cigarette
company
Lohinai, Zoltan Planner Nothing to disclose Nothing to disclose
Lok, Benjamin Planner Nothing to disclose Nothing to disclose
Loong, Herbert Education
Committee
1) Boehringer Ingelheim, Eisai, Eli-Lilly
2) Eisai, Novartis
3) MSD, Mundipharma, Novartis
1) Advisory Board
2) Speakers Bureau
3) Contracted/Support Research
Grant
Louie Alex Education
Committee
1) AstraZeneca
2) Varian Medical Systems Inc.
1) Advisory Board
2) Speakers Bureau
Lovly, Christine Planner 1) BLuePrints Medicine, Takeda, Genentech, Achilles, Foundation
Medicine
2) Foundation Medicine
3) Honorarium from Advisory Boards: BLuePrints Medicine, Takeda,
Genentech, Achilles, Foundation Medicine
1) Advisory Board
2) Consultant
3) Other
Lu, Shun Planner 1) Astra Zeneca
2) Astra Zeneca, Roche, Hutchison MediPharma,
3) BMS, Zai Lab
1) Speakers Bureau
2) Advisory Board
3) Consultant
Lu, You Planner 1) Consulting/advisory role, AstraZeneca; Pfizer; Bristol-Myers
Squibb; Merck Sharp & Dohme; Roche/Genentech
2) Supported research grant role, AstraZeneca; Pfizer
1) Consultant
2) Contracted/Supported Research
Grant
Madabhushi, Anant Planner 1) Self, Inspirata Inc.,
2) Self, Inspirata Inc, Merck, Bristol-Meyers Squibb
3) Self, Inspirata Inc, Elucid Bioimaging
4) Self, Philips
5) Self, Inspirata Inc.
1) Advisory Board
2) Consultant
3) Ownership/Stock Interest
4) Contracted/Supported Research
Grant
5) Royalties/Intellectual
Property/Patent Holder
Madegedara,
Dushantha
Planner Nothing to disclose Nothing to disclose
Mcwilliams,
Annette
Planner 1) Travel support by Roche- I was an invited speaker to attend a
Study day in Sydney Australia- Roche paid fro travel and
accommodation. Cancer Australia has also provided travel support
to attend workshops in Syndey. I have also received travel and
accommodation support from Olympus to attend an annual
research meeting in Australia + New Zealand.
1) Other
Page 10 of 16
Planner Disclosure Summary
Name of Individual Individual's
Role(s) in
Activity
Name of Commercial Interest(s) Nature of Relationship(s)
Meldgaard, Peter Planner Nothing to disclose Nothing to disclose
Mezquita, Laura Planner 1) Tecnofarma
2) Roche, Takeda
3) Mentorship Program funded by AstraZeneca
1) Speakers Bureau
2) Advisory Board
3) Other
Mohindra Pranshu Education
Committee
Nothing to disclose Nothing to disclose
Molassiotis, Alex Planner Nothing to disclose Nothing to disclose
Mori, Masanori Planner Nothing to disclose Nothing to disclose
Morris, Lucinda Planner Nothing to disclose Nothing to disclose
Murgu, Septimiu Planner 1) Olympus, Boston Scientific, Pinnacle Biologics and Cook Inc
2) Elsevier ( for textbook on Bronchoscopy)
3) Chair of Education Committee for CHEST and President-elect
AABIP
1) Consultant
2) Royalties/Intellectual
Property/Patent Holder
3) Other
Nagata, Yasushi Planner Nothing to disclose Nothing to disclose
Nakagawa,
Kazuhiko
Planner 1) Astellas Pharma Inc./Takeda Pharmaceutical Co.,Ltd.
2) "Astellas Pharma Inc./Takeda Pharmaceutical
Co.,Ltd./AstraZeneca K.K./Chugai Pharmaceutical Co.,Ltd./ MSD
K.K./Eli Lilly Japan K.K. /Ono Pharmaceutical Co.,Ltd./Nippon
Boehringer Ingelheim Co.,Ltd./ Daiichi Sankyo Co., Ltd./Novartis
Pharma K.K. / Taiho Pharmaceutical Co.,Ltd./Pfizer Japan
Inc./Bristol Myers Squibb Company/Nikkei Business Publications,
Inc./KYORIN Pharmaceutical Co.,Ltd./MEDICUS
SHUPPAN,Publishers Co., Ltd. /CareNet,Inc/Thermo Fisher
Scientific K.K. /Nichi-Iko Pharmaceutical Co., Ltd./NANZANDO
Co.,Ltd/ Hisamitsu Pharmaceutical Co.,Inc./Medical Review Co.,
Ltd. / YODOSHA CO., LTD./YOMIURI TELECASTING CORPORATION."
3) "MSD K.K./AstraZeneca K.K./ICON Japan K.K./Astellas Pharma
Inc./Takeda Pharmaceutical Co.,Ltd./Novartis Pharma K.K./Eli
Lilly Japan K.K./Quintiles Inc./Bristol Myers Squibb Company/CMIC
Shift Zero K.K./ Taiho Pharmaceutical Co.,Ltd./Eisai Co., Ltd.
/PAREXEL International Corp./Nippon Boehringer Ingelheim
Co.,Ltd. / Ono Pharmaceutical Co.,Ltd./Kissei Pharmaceutical
Co.,Ltd./IQVIA./Pfizer Japan Inc./ A2 Healthcare Corp./Kyowa
Hakko Kirin Co.,Ltd / AbbVie Inc./EPS Corporation. / Chugai
Pharmaceutical Co.,Ltd./Daiichi Sankyo Co., Ltd./ SymBio
Pharmaceuticals Limited./Bayer Yakuhin, Ltd / Merck Serono
Co., Ltd."
1) Consultant
2) Honorarium received from
promotional activities
3) Contracted/Supported Research
Grant
Nazareth Aguiar
Junior, Pedro
Planner Nothing to disclose Nothing to disclose
Neal, Joel Education
Committee
1) AstraZeneca, Eli Lilly, Exelixis, Genetech/Roche, Jounce
Therapeutics, Takeda
2) Adaptimmune, Boehringer Ingelheim, Exelixis,
Genetech/Roche, GSK, Merck, Nektar, Novartis, Takeda
1) Advisory Board
2) Contracted/Support Research
Grant
O'Hallahan, Jane Planner Nothing to disclose Nothing to disclose
Page 11 of 16
Planner Disclosure Summary
Name of Individual Individual's
Role(s) in
Activity
Name of Commercial Interest(s) Nature of Relationship(s)
Ong, Boon-Hean Planner 1) I received a honorarium and travel expenses to attend an
international consensus meeting on use of ICG in thoracic surgery
in Hong Kong in July 2019 from Stryker. I also received
reimbursement for travel and accommodation to attend a thoracic
surgery workshop in Hong Kong in July 2019 from Johnson &
Johnson.
1) Other
Ortiz-Cuaran,
Sandra
Planner Nothing to disclose Nothing to disclose
Osarogiagbon, Ray Planner 1) Association of Community Cancer Centers
2) Eli Lilly, Pfizer
3) Owner of patents for surgical specimen collection kit.
1) Consultant
2) Ownership/Stock Interest
3) Royalties/Intellectual
Property/Patent Holder
Ou, Sai-Hong Planner 1) Pfizer, Roche/Genentech, Takeda/ARIAD, Merck, Astra Zeneca
2) Pfizer, Roche/Genetech, Takeda/ARAID, Astrazeneca
3) Turning Point Therapeutics, AnHeart Therapeutics
4) Turning Point Therapeutics
5) Pfizer, Takeda/ARIAD, Roche, Astra Zeneca, Geneseeq
laboratories
1) Speakers Bureau
2) Advisory Board
3) Consultant
4) Ownership/Stock Interest
5) Honorarium received from
promotional activities
Owonikoko,
Taofeek
Planner 1) Novartis, Celgene, Lilly, Sandoz, Abbvie, Eisai, G1
Therapeutics, Takeda, Seattle Genetics, Bristol-Myers Squibb,
MedImmune, BerGenBio, Lilly, Amgen, AstraZeneca, PharmaMar,
Boehringer Ingelheim, EMD Serono, Xcovery, Bayer, Heron
Pharmaceutical, ARMO BioSciences, Merck, Bayer
2) Cambium Oncology
3) Novartis; Astellas Pharma, Bayer, StemCentRx, Regeneron,
AstraZeneca/MedImmune, Abbvie, G1 Therapeutics, Bristol-
Myers, Corvus Pharmaceuticals, United Therapeutics, Amgen,
Loxo/Lilly, Fujifilm, Pfizer, Aeglea Biotherapeutics, Incyte, Merck
1) Advisory Board
2) Ownership/Stock Interest
3) Contracted/Supported Research
Grant
Oxnard, Geoffrey Planner 1) AstraZeneca, Blueprint, Illumina, Janssen, Genentech
2) DropWorks, Foundation Medicine
1) Advisory Board
2) Consultant
Pan-Chyr, Yang Planner Nothing to disclose Nothing to disclose
Pass, Harvey Planner 1) Wife: genentech and genomic health
2) Astra Zeneca; Novartis Roche; Loxo; Genentech
3) Biodesix, Co-factor Genomics, SomaLogic
4) NCI, mesothelioma cell lines; Patent for Osteopontin for
diagnosis of mesothelioma
1) Speakers Bureau
2) Advisory Board
3) Contracted/Supported Research
Grant
4) Royalties/Intellectual
Property/Patent Holder
Patel, Jyoti Education
Committee
1) AbbVie, AstraZeneca, Takeda 1) Consultant
Page 12 of 16
Planner Disclosure Summary
Name of Individual Individual's
Role(s) in
Activity
Name of Commercial Interest(s) Nature of Relationship(s)
Peters, Solange Planner 1) Abbvie, Amgen, AstraZeneca, Bayer, Biocartis, Bioinvent,
Blueprint Medicines, Boehringer-Ingelheim, Bristol-Myers Squibb,
Clovis, Daiichi Sankyo, Debiopharm, Eli Lilly, F. Hoffmann-La
Roche, Foundation Medicine, Illumina, Janssen, Merck Sharp and
Dohme, Merck Serono, Merrimack, Novartis, Pharma Mar, Pfizer,
Regeneron, Sanofi, Seattle Genetics and Takeda
2) Stallites symposia only: AstraZeneca, Boehringer-Ingelheim,
Bristol-Myers Squibb, Eli Lilly, F. Hoffmann-La Roche, Illumina,
Merck Sharp and Dohme, Novartis, Pfizer, Sanofi, Takeda
3) (Sub)investigator in trials (institutional financial support for
clinical trials) sponsored by Amgen, AstraZeneca, Biodesix,
Boehringer-Ingelheim, Bristol-Myers Squibb, Clovis, F. Hoffmann-
La Roche, Illumina, Merck Sharp and Dohme, Merck Serono,
Novartis, and Pfizer
1) Advisory Board
2) Honorarium received from
promotional activities
3) Contracted/Supported Research
Grant
Pilotto, Sara Planner 1) AstraZeneca, MSD, Boehringer Ingelheim, BMS, Roche
2) MSD, Boehringer Ingelheim, BMS
3) Boehringer Ingelheim, Roche, TRM Oncology
4) AstraZeneca
1) Speakers Bureau
2) Advisory Board
3) Consultant
4) Contracted/Supported Research
Grant
Popat, Sanjay Planner 1) BMS, Roche, Takeda, AstraZeneca, Chugai, Novartis, Pfizer,
MSD, EMD Serono, Guardant Health, AbbVie, Boehringer Ingelheim,
Tesaro, Incyte
2) BMS, Roche, Takeda, AstraZeneca, Chugai, Novartis, Pfizer,
MSD, EMD Serono, Guardant Health, AbbVie, Boehringer Ingelheim,
Tesaro, Incyte
3) Elsevier
1) Advisory Board
2) Consultant
3) Employment
Qu, Melody Planner Nothing to disclose Nothing to disclose
Quist, Morten Planner 1) 1971 1) Financial support or relationship
with tobacco and/or e-cigarette
company
Reck, Martin Planner 1) Amgen, AstraZeneca, BMS, Boehringer-Ingelheim, Celgene,
Lilly, Merck, MSD, Novartis, Pfizer, Roche
2) Amgen, AstraZeneca, BMS, Boehringer-Ingelheim, Celgene,
Lilly, Merck, MSD, Novartis, Pfizer, Roche
3) BMS
1) Speakers Bureau
2) Advisory Board
3) Contracted/Supported Research
Grant
Reguart, Noemi Planner 1) Astra-Zeneca, MSD, BI, Roche, BMS
2) Astra-Zeneca, Pfizer, MSD, Novartis, BI
3) Pfizer, Novartis
1) Speakers Bureau
2) Advisory Board
3) Contracted/Supported Research
Grant
Reinmuth, Niels Planner 1) Astra Zeneca, Böhringer-Ingelheim, BMS, Roche, MSD, Takeda,
Abbvie
2) Astra Zeneca, Böhringer-Ingelheim, BMS, Roche, MSD, Takeda,
Abbvie
1) Speakers Bureau
2) Advisory Board
Ren, Shengxiang Education
Committee
Nothing to disclose Nothing to disclose
Page 13 of 16
Planner Disclosure Summary
Name of Individual Individual's
Role(s) in
Activity
Name of Commercial Interest(s) Nature of Relationship(s)
Reungwetwattana,
Associate
Professor
Thanyanan
Planner 1) Astrazeneca, Roche, Novartis, MSD
2) Astrazeneca, Roche, Novartis, MSD
1) Advisory Board
2) Contracted/Supported Research
Grant
Rolfo, Christian
Diego
Education
Committee
1) Mylan, Oncompass
2) MSD, GuardantHealth
3) OncoDNA, Biomark, Guardanthealth
1) Advisory Board
2) Honorarium
3) Contracted/Support Research
Grant
Samol, Jens Planner Nothing to disclose Nothing to disclose
Samson, Pamela Planner Nothing to disclose Nothing to disclose
Sands, Jacob Planner 1) Medtronic, AstraZeneca, Foundation Medicine, Guardant, Loxo,
Abbvie
1) Advisory Board
Santini, Fernando Planner 1) AstraZeneca; MSD; Bayer
2) Lilly; Bayer; MSD; AstraZeneca
3) Roche; MSD; Bayer; AstraZeneca; BMS; Novartis
1) Speakers Bureau
2) Advisory Board
3) Honorarium received from
promotional activities
Schalper, Kurt Planner 1) Merck, Bristol Myers Squibb and Fluidigm
2) Celgene, Shattuck Labs, Pierre-Fabre, Astrazeneca, Dynamo
Therapeutics and Agenus
3) Clinica Alemana Santiago, Moderna Therapeutics, EMD Serono,
Takeda, Torque Therapeutics
4) Yale University
5) Navigate Bipharma (Novartis), Vasculox/Tioma, Tesaro,
Moderna Thrapeutics, Takeda Pharmaceuticals, Surface Oncology,
Pierre-Fabre Research Institute, Merck, Bristol-Myers Squibb,
AstraZeneca and Eli Lilly.
1) Speakers Bureau
2) Advisory Board
3) Consultant
4) Employment
5) Contracted/Supported Research
Grant
Schoenherr, Grit Planner Nothing to disclose Nothing to disclose
Sholl, Lynette Planner 1) LOXO Oncology
2) AstraZeneca
3) Roche/Genentech
1) Advisory Board
2) Honorarium received from
promotional activities
3) Contracted/Supported Research
Grant
Singh, Navneet Planner Nothing to disclose Nothing to disclose
Skoulidis,
Ferdinandos
Planner 1) Tango Therapeutics 1) Consultant
Soo, Ross Planner 1) Astra-Zeneca, BMS, Boehringer Ingelheim, Lilly, Merck,
Novartis, Pfizer, Roche, Taiho, Takeda, Yuhan
2) Astra-Zeneca, Boehringer Ingelheim
1) Advisory Board
2) Contracted/Supported Research
Grant
Steliga, Matthew Planner Nothing to disclose Nothing to disclose
Stone, Emily Planner 1) Non-financial support: Boehringer-Ingelheim - travel and
accommodation to attend AIRWAYS 2019
1) Other
Suarez, Francisco Education
Committee
Nothing to disclose Nothing to disclose
Suda, Kenichi Planner 1) Boehringer Ingelheim (myself)
2) AstraZeneca (myself)
3) Rain Therapeutics and Boehringer Ingelheim (myself)
1) Speakers Bureau
2) Advisory Board
3) Contracted/Supported Research
Grant
Page 14 of 16
Planner Disclosure Summary
Name of Individual Individual's
Role(s) in
Activity
Name of Commercial Interest(s) Nature of Relationship(s)
Takano, Angela Planner Nothing to disclose Nothing to disclose
Tam, Wai Leong Planner Nothing to disclose Nothing to disclose
Tan, Daniel Education
Committee
1) Pfizer, Novartis, AstraZeneca, Celgene, MSD, Takeda, Loxo,
Merrimack
2) Merck, Roche, Pfizer
3) Novartis, GSK, Astra Zeneca
1) Advisory Board
2) Honorarium
3) Novartis, GSK, AstraZeneca
Tan, Wan Ling Planner 1) National Cancer Centre Singapore 1) Financial support or relationship
with tobacco and/or e-cigarette
company
Tanaka, Yuko Planner Nothing to disclose Nothing to disclose
Tenda, Dr Eric
Daniel
Planner Nothing to disclose Nothing to disclose
Tsao, Anne Planner 1) BMS, Eli Lilly, Genentech, Roche, Novartis, Ariad, EMD Serono,
Merck, Seattle Genetics, Astra-Zeneca, Boehringer-Ingelheim,
Sellas Life Science, Takeda, Epizyme, Huron
2) MD Anderson cancer center
3) Eli Lilly, Millennium, Polaris, Genentech, Merck, Boehringer-
Ingelheim, BMS, Ariad, Epizyme, Seattle Genetics, Takeda, EMD
Serono
1) Advisory Board
2) Employment
3) Contracted/Supported Research
Grant
Turna, Akif Planner Nothing to disclose Nothing to disclose
Vallone, Stefania Planner Nothing to disclose Nothing to disclose
Warren, Graham Planner 1) Medical University of South Carolina 1) Financial support or relationship
with tobacco and/or e-cigarette
company
Watanabe, Shun-
Ichi
Planner Nothing to disclose Nothing to disclose
Wolf, Andrea Planner Nothing to disclose Nothing to disclose
Wozniak,
Antoinette
Education
Committee
1) Boehringer Ingelheim
2) Karyopharm, HUYA, BeyondSpring
3) Boehringer Ingelheim
1) Advisory Board
2) Consultant
3) Contracted/Supported Research
Grant
Wu, Ning Planner Nothing to disclose Nothing to disclose
Wu, Yi-Long Planner 1) AstraZeneca; Boehringer Ingelheim;
2) Speaker fees from AstraZeneca, Roche, Boehringer Ingelheim;
Pfizer; BMS; MSD; Eli Lilly (all not promotional activities)
3) AstraZeneca, Roche, Boehringer Ingelheim
1) Advisory Board
2) Honorarium received from
promotional activities
3) Contracted/Supported Research
Grant
Yamaoka, Satoko Planner Nothing to disclose Nothing to disclose
Yang, Fan Planner Nothing to disclose Nothing to disclose
Yang, Grace Planner 1) National Cancer Centre 1) Financial support or relationship
with tobacco and/or e-cigarette
company
Page 15 of 16
Planner Disclosure Summary
Name of Individual Individual's
Role(s) in
Activity
Name of Commercial Interest(s) Nature of Relationship(s)
Yang, James Chih-
Hsin
Planner 1) Boehringer Ingelheim, Eli Lilly, Bayer,
Roche/Genentech/Chugai, MSD, Merck Serono, Pfizer, Novartis,
Celgene, Yuhan Pharmaceuticals, BMS, Ono pharmaceutical,
Daiichi Sankyo, Astrazeneca, Takeda Oncology and Hansoh
Pharmaceutical
2) Boehringer Ingelheim, Merck Serono, Novartis, Yuhan
Pharmaceuticals, BMS, Ono pharmaceutical, Daiichi Sankyo,
Astrazeneca and Takeda Oncology
1) Advisory Board
2) Consultant
Yano, Seiji Planner 1) AstraZeneca, Chugai Pharma, Taiho Pharma, Novartis,
Boehringer-Ingelheim, Pfizer
2) Chugai Pharma, Boehringer-Ingelheim, Novartis, Taiho Pharma,
Pfizer, MSD, Bayer, Daiichi-Sankyo, Shionogi, Eisai, Ohtsuka
1) Speakers Bureau
2) Contracted/Supported Research
Grant
Yatabe, Yasushi Planner 1) MDS, Chugai-pharma, Novartis, Pfizer, AstraZeneca 1) Speakers Bureau
Ynoe De Moraes,
Fabio
Planner Nothing to disclose Nothing to disclose
Yom, Sue Education
Committee
Nothing to disclose Nothing to disclose
Yorke, Janelle Planner 1) Nellie primary 1) Financial support or relationship
with tobacco and/or e-cigarette
company
Zhang, Li Planner 1) MSD, AZ, Pfizer, Henrui Pharm
2) AZ, MSD, BMS
1) Speakers Bureau
2) Advisory Board
Zhong, Wen-Zhao Education
Committee
1) AstraZeneca 1) Speakers Bureau
Zhou, Caicun Education
Committee
1) Roche, Eli Lily, Boehringer Ingelheim, Merck, Hengrui, Qiru 1) Honorarium
Zhou, Qing Planner 1) I received honoraria from AstraZeneca, Roche. 1) Honorarium received from
promotional activities
Page 16 of 16